Skip to main content

Main menu

  • All Issues
    • Current Issue
    • Archive
  • Collections
    • 2017 AJHP Top Twenty-Five Articles
    • ASHP National Surveys of Pharmacy Practice in Hospital Settings
    • Credentialing/Privileging
    • Drug Expenditures
    • Opioids
    • Pharmacy Technicians
    • Population Health Management Theme Issue
    • Specialty Pharmacy
    • Transitions of Care/Medication Reconciliation
  • AJHP Residents Edition
  • AJHP Voices
  • Information For
    • Authors/Reviewers
    • Members/Subscribers
    • Institutions/Libraries
    • Advertisers
  • About AJHP
    • Mission and Vision
    • Editorial Staff
    • Editorial Board
    • AJHP Sections and Columns
    • Reprints and Permissions
  • Other Publications
    • American Society of Health-System Pharmacists

User menu

  • Subscribe
  • My Alerts
  • Log In

Search

  • Advanced search
American Journal of Health-System Pharmacy
  • Other Publications
    • American Society of Health-System Pharmacists
  • Subscribe
  • My Alerts
  • Log In
  • Follow AJHP on ASHP Connect
  • Follow ajhp on Twitter
  • Visit ajhp on Facebook
American Journal of Health-System Pharmacy

Advanced Search

  • All Issues
    • Current Issue
    • Archive
  • Collections
    • 2017 AJHP Top Twenty-Five Articles
    • ASHP National Surveys of Pharmacy Practice in Hospital Settings
    • Credentialing/Privileging
    • Drug Expenditures
    • Opioids
    • Pharmacy Technicians
    • Population Health Management Theme Issue
    • Specialty Pharmacy
    • Transitions of Care/Medication Reconciliation
  • AJHP Residents Edition
  • AJHP Voices
  • Information For
    • Authors/Reviewers
    • Members/Subscribers
    • Institutions/Libraries
    • Advertisers
  • About AJHP
    • Mission and Vision
    • Editorial Staff
    • Editorial Board
    • AJHP Sections and Columns
    • Reprints and Permissions
Articles

Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom

ND Barber, R Batty and DA Ridout
American Journal of Health-System Pharmacy February 1997, 54 (4) 397-405;
ND Barber
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R Batty
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DA Ridout
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Pharmacists' clinical interventions in a group of British hospitals were counted, and a model to determine factors that affected the intervention rate was developed. All pharmacists who visited patient wards in 27 acute care hospitals recorded their daily ward visits and their clinical interventions during five consecutive days (Monday through Friday) in June 1993. An intervention was defined as any recommendation made with the intent of changing drug treatment. Mixed-model Poisson regression was used to try to explain variations in the intervention rate, defined as the number of physician-accepted interventions divided by the number of occupied-bed days. Possible predictors of intervention rate considered were characteristics of the hospitals, the wards, and the pharmacists. During the study period, 248 pharmacists visited 10,478 beds and proposed 3,501 interventions. Of these interventions, 3371 were accepted, 56 were rejected, and 74 were unresolved. The most frequent reasons for the interventions involved the dose (29%), the need for therapy (21%), the choice of drug (14%), and the route (12%). Ward type, pharmacist grade, and the total time the pharmacist spent on the wards were significant predictors of the intervention rate. To validate the model, data were collected during the same period in 1994; the model predicted the number of interventions within 1 of the actual number in 82% of cases. In a model explaining the factors that affected the rate of physician-accepted pharmacist interventions in acute care hospitals in the United Kingdom, ward type, pharmacist grade, and total time spent on the ward by the pharmacist were significant predictors of the intervention rate.

  • Copyright © 1997 by American Society of Health-System Pharmacists
PreviousNext
Back to top

In this issue

American Journal of Health-System Pharmacy
Vol. 54, Issue 4
15 Feb 1997
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Journal of Health-System Pharmacy.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom
(Your Name) has sent you a message from American Journal of Health-System Pharmacy
(Your Name) thought you would like to see the American Journal of Health-System Pharmacy web site.
Citation Tools
Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom
ND Barber, R Batty, DA Ridout
American Journal of Health-System Pharmacy Feb 1997, 54 (4) 397-405;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom
ND Barber, R Batty, DA Ridout
American Journal of Health-System Pharmacy Feb 1997, 54 (4) 397-405;
ASHP Connect logo del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Current and emerging therapies for patients with advanced non-small-cell lung cancer
  • Histological and genetic markers for non-small-cell lung cancer: Customizing treatment based on individual tumor biology
  • Introduction
Show more Articles

Similar Articles

Content

  • Current Issue
  • All Issues
  • Collections
  • AJHP Resident Edition
  • AJHP Supplements
  • Ahead of Print

Navigate

  • AJHP Voices
  • AJHP Statement of Ownership
  • Order Reprints
  • Request Permissions

Follow/Contact AJHP

  • Twitter
  • RSS
  • Alerts
  • Contact Us
  • Feedback
  • Help

Information For

  • Authors/Reviewers
  • Members/Subscribers
  • Institutions/Libraries
  • Advertisers

Other Resources

  • ASHP
  • ASHP Foundation
  • ASHP eLearning

Copyright © 2018  by American Society of Health-System Pharmacists